Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
Middle ear adenomas with neuroendocrine features (ANEF) are rare, with an estimated 150 reported cases. They usually pursue an indolent clinical course. Four reported cases of middle ear ANEF with distant metastases were treated with surgery, external beam radiation therapy (EBRT) and chemotherapy....
Main Authors: | Joana Lima Ferreira, Bernardo Marques, C Willemien Menke-van der Houven van Oordt, Wouter W de Herder, Tessa Brabander, Johannes Hofland |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2021-05-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2021/1/EDM20-0172.xml |
Similar Items
-
Neuroendocrine adenoma of the middle ear—An intriguing entity
by: Peter Bou Rahal, et al.
Published: (2021-03-01) -
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
by: Anna Kathrin Stueven, et al.
Published: (2019-06-01) -
Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
by: Kiesewetter, B., et al.
Published: (2022) -
Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.
by: Sebastian Krug, et al.
Published: (2019-01-01) -
Somatostatin analogues in the therapy of neuroendocrine tumors: Indications, contraindications, side-effects
by: Beata Polowczyk, et al.
Published: (2020-07-01)